France's Ipsen has expanded its oncology pipeline by licensing a T-cell engager (TCE) therapy from Paris-based start-up Biomunex Pharmaceuticals. The deal – valued at up to $610 million ...

Ipsen's consumer health range includes brands like diarrhoea remedy Smecta, Forlax for constipation and Ginkgo biloba supplement Tanakan, which recorded revenues of €226 million in 2021, up 8%.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Ipsen Biopharmaceuticals must face a former patient safety employee’s religious bias claims over her alleged firing for refusing to receive a Covid-19 vaccination, the First Circuit ruled. Regina M.

Representatives from ABAR Office will respond to you via e-mail. By sending this message you agree to the T&C.